Name: India approves Russia's Sputnik V COVID-19 vaccine
Brand: reuters.com
SKU: reuters-com-3098
Availability: OnlineOnly

critic

India approves Russia's Sputnik V COVID-19 vaccine

preview

A medical worker prepares a dose of the Sputnik V vaccine against the coronavirus disease (COVID-19) in Caracas, Venezuela April 9, 2021. REUTERS/Leonardo Fernandez Viloria Register now for FREE unlimited access to Reuters.comBENGALURU, April 12 (Reuters) - India has approved the use of Russian Sputnik V COVID-19 vaccine, the Russian Direct Investment Fund (RDIF) said on Monday, confirming earlier reports of its imminent endorsement.India overtook Brazil to become the nation with the second highest number of infections worldwide after the United States, as it battles a second wave, having given about 105 million doses among a population of 1.4 billion. The RDIF, which is responsible for marketing the vaccine abroad, said the Drug Controller General of India (DCGI) had approved the use of Sputnik V.Register now for FREE unlimited access to Reuters.com"India, the world’s 2nd most populous nation, became the 60th country to register #SputnikV after positive results of local Phase 3 clinical study. Sputnik V is now authorized in 60 countries with population of over 3 bln people," a post on the Sputnik V official Twitter account said.Earlier on Monday, two people familiar with the matter said the panel of the Central Drugs Standard Control Organisation (CDSCO) had recommended the authorisation.The RDIF has signed deals to produce more than 750 million doses of Sputnik V in India with six domestic firms.India has so far used two vaccines, one developed by AstraZeneca and Oxford University, and the other by domestic firm Bharat Biotech.Sputnik V, developed by Moscow's Gamaleya Institute, has proved 91.6% effective against COVID-19 and has been approved for use in more than 50 countries.The Indian drugs regulator did not respond to a request for comment on the expert panel's approval of the Russian vaccine.Indian pharmaceutical firm Dr. Reddy's, which is marketing the vaccine in India, said it was awaiting formal word from the authorities."Dr. Reddy’s and RDIF are working diligently with the Indian regulatory authorities to obtain the approval for Sputnik V. We are fully committed to playing our part in India’s fight against COVID," the company said.Shares of Dr Reddy's ended up 5% after the Economic Times newspaper first reported the news.The firm has helped run a small domestic trial to test the vaccine's safety and ability to generate an immune response.Register now for FREE unlimited access to Reuters.comOur Standards:

A medical worker prepares a dose of the Sputnik V vaccine against the coronavirus disease (COVID-19) in Caracas, Venezuela April 9, 2021. REUTERS/Leonardo Fernandez Viloria Register now for FREE unlimited access to Reuters.comBENGALURU, April 12 (Reuters) - India has approved the use of Russian Sputnik V COVID-19 vaccine, the Russian Direct Investment Fund (RDIF) said on Monday, confirming earlier reports of its imminent endorsement.India overtook Brazil to become the nation with the second highest number of infections worldwide after the United States, as it battles a second wave, having...

public

Nigam Prusty

Krishna N. Das

Top and breaking news, pictures and videos from Reuters. For more breaking business news, follow @ReutersBiz.

reuters.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

India approves Russia's Sputnik V COVID-19 vaccine

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS